Enveric Biosciences Inc (ENVB) Stock Price, Quote & News

Company Profile

Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuro...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 444 8400

Website: www.enveric.com

Address:

245 First Street, Riverview II 18 th Floor, Cambridge, United States

Trade_Weaver Jul. 1 at 12:15 PM

$ENVB what does this stock have in the pipeline?

1 · Reply

SWEEN24 Jul. 1 at 12:43 AM

$ENVB in!

0 · Reply

2TrustHim Jun. 26 at 9:08 PM

$ENVB Is This Running To Another Level Next Week?

0 · Reply

TheFlash Jun. 25 at 5:25 PM

$ENVB tipranks.com/news/the-fly/psychedelic-definium-soars-on-study-results-for-lsd-based-depression-treatment-thefly-news

0 · Reply

TheFlash Jun. 25 at 5:20 PM

$ENVB Psychedelic: "Definium soars on study results for LSD-based depression treatment." Right up their alley. This will explode with news which should be soon. Chart at dead bottom.

0 · Reply

bioebi Jun. 24 at 11:50 PM

$ENVB $PLSM $CUPR $CDT ENVB: next 100% Runner Enveric Biosciences (NASDAQ: ENVB) operates with zero total debt and roughly $4.91M in cash. ENVB shares surged significantly (upwards of 140% to 160% in a single session) on news that the FDA was instructed to cut red tape around psychedelic drug approvals.Fast-Tracking Therapies: The directive directed the FDA to issue vouchers that could potentially cut the standard drug review time from 6-10 months down to 1-2 months.

1 · Reply

bioebi Jun. 24 at 11:46 PM

$ENVB $CDT $DAIC $MWYN ENVB: this is my next 100% Runner

1 · Reply

Luckyjs38 Jun. 22 at 4:54 PM

$ENVB

0 · Reply

andre82 Jun. 22 at 3:42 PM

$PSTV working on a fund that is 3x inverse performance of Mo tickers. The weighting of the tickers is correlated to how often they get tagged. Make the scammers work for you! 😂😂 $JAGX $NUWE $BDRX $ENVB

1 · Reply

yenkins Jun. 17 at 7:52 PM

$PSTV $NUWE $SINT $ENVB $JAGX

1 · Reply

Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit

Jun 16, 2026, 9:28 AM EDT - 18 days ago

Enveric Biosciences Announces Participation in 2026 BIO International Convention

Jun 9, 2026, 8:00 AM EDT - 25 days ago

Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day

2026-06-02T13:40:18.000Z - 4 weeks ago

Enveric Biosciences initiates IND-enabling Genotoxicity studies of EB-003

Jun 2, 2026, 8:00 AM EDT - 4 weeks ago

Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003

2026-05-19T12:19:47.000Z - 6 weeks ago

Enveric Biosciences reports preclinical results from analysis of EB-003

May 19, 2026, 8:00 AM EDT - 6 weeks ago

Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003

2026-05-15T13:30:05.000Z - 7 weeks ago

Enveric Biosciences reports Q1 EPS ($1.08) vs. ($14.58) last year

2026-05-15T13:28:31.000Z - 7 weeks ago

Enveric Biosciences sees cash runway into 1Q27

May 15, 2026, 8:00 AM EDT - 7 weeks ago

Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026

2026-05-13T16:39:18.000Z - 7 weeks ago

Enveric issued U.S. patent for methods of treating psychiatric disorders

May 13, 2026, 8:00 AM EDT - 7 weeks ago

Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders

2026-05-05T12:19:49.000Z - 2 months ago

Enveric Biosciences highlights preclinical data for EB-003

May 5, 2026, 8:00 AM EDT - 2 months ago

Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model

2026-04-30T19:26:43.000Z - 2 months ago

Enveric Biosciences trading resumes

2026-04-30T13:43:15.000Z - 2 months ago

Enveric Biosciences trading halted, volatility trading pause

Apr 28, 2026, 7:33 AM EDT - 2 months ago

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors

LABT

2026-04-23T23:30:54.000Z - 2 months ago

Enveric Biosciences files to sell 6.82M shares of common stock

2026-04-21T17:19:08.000Z - 2 months ago

3 Penny Stocks to Watch Now, 4/21/26

PBM TOVX

Apr 21, 2026, 8:00 AM EDT - 2 months ago

Enveric Biosciences to Participate in a Panel Discussion at Needham's Virtual Psychedelics Forum

Apr 20, 2026, 6:43 AM EDT - 2 months ago

Psychedelic drug makers rally as Trump orders FDA to expedite reviews

ATAI CMPS DFTX GHRS HELP

Apr 17, 2026, 6:28 PM EDT - 2 months ago

Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

2026-04-17T00:05:12.000Z - 2 months ago

Enveric Biosciences prices $13.9M at-the-market offering

Apr 16, 2026, 8:00 PM EDT - 2 months ago

Enveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

2026-03-31T12:12:19.000Z - 3 months ago

Enveric Biosciences secures new U.S. patent for its EVM301 series

Mar 31, 2026, 8:00 AM EDT - 3 months ago

Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates

Mar 27, 2026, 5:40 PM EDT - 3 months ago

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025

Mar 18, 2026, 8:00 AM EDT - 3 months ago

Enveric Biosciences Announces Registration of Five Trademarks

Feb 25, 2026, 8:00 AM EST - 4 months ago

Enveric Biosciences Announces Withdrawal of Petition Against Its Patent

Feb 19, 2026, 8:00 AM EST - 4 months ago

Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data

Jan 29, 2026, 8:00 AM EST - 5 months ago

Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option

Jan 28, 2026, 5:00 PM EST - 5 months ago

Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jan 28, 2026, 8:00 AM EST - 5 months ago

Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Dec 29, 2025, 8:00 AM EST - 6 months ago

Enveric Biosciences Announces Patent Issuance

Dec 12, 2025, 4:46 PM EST - 7 months ago

Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds

Dec 11, 2025, 1:43 PM EST - 7 months ago

Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds

Dec 9, 2025, 8:00 AM EST - 7 months ago

Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates

Dec 4, 2025, 8:00 AM EST - 7 months ago

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”

Nov 26, 2025, 8:00 AM EST - 7 months ago

Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates

Nov 14, 2025, 4:05 PM EST - 8 months ago

Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results

Oct 23, 2025, 8:00 AM EDT - 9 months ago

Enveric Biosciences Announces Reverse Stock Split

Oct 16, 2025, 8:30 AM EDT - 9 months ago

Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance

Oct 15, 2025, 8:00 AM EDT - 9 months ago

Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal

Oct 14, 2025, 9:00 AM EDT - 9 months ago

Enveric Biosciences to Explore Digital Asset Treasury Opportunities

Oct 2, 2025, 8:45 AM EDT - 9 months ago

Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials

Sep 18, 2025, 4:30 PM EDT - 10 months ago

Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds

Sep 17, 2025, 9:24 AM EDT - 10 months ago

Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds

Sep 17, 2025, 8:00 AM EDT - 10 months ago

Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery

Sep 16, 2025, 8:45 AM EDT - 10 months ago

Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission

Sep 3, 2025, 8:30 AM EDT - 10 months ago

Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:30 AM EDT - 10 months ago

Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA

Aug 28, 2025, 8:30 AM EDT - 11 months ago

Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications

Aug 14, 2025, 8:00 AM EDT - 11 months ago

Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results

Jul 23, 2025, 8:03 AM EDT - 1 year ago

Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series

Jul 15, 2025, 9:03 AM EDT - 1 year ago

Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)

Jun 24, 2025, 9:03 AM EDT - 1 year ago

Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003

Jun 16, 2025, 10:46 AM EDT - 1 year ago

Enveric Biosciences Announces Participation in 2025 BIO International Convention

Jun 10, 2025, 9:03 AM EDT - 1 year ago

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders

Jun 3, 2025, 9:00 AM EDT - 1 year ago

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds

May 28, 2025, 9:03 AM EDT - 1 year ago

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003

May 20, 2025, 8:00 AM EDT - 1 year ago

Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease

May 14, 2025, 4:15 PM EDT - 1 year ago

Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results

Trade_Weaver Jul. 1 at 12:15 PM

$ENVB what does this stock have in the pipeline?

1 · Reply

SWEEN24 Jul. 1 at 12:43 AM

$ENVB in!

0 · Reply

2TrustHim Jun. 26 at 9:08 PM

$ENVB Is This Running To Another Level Next Week?

0 · Reply

TheFlash Jun. 25 at 5:25 PM

$ENVB tipranks.com/news/the-fly/psychedelic-definium-soars-on-study-results-for-lsd-based-depression-treatment-thefly-news

0 · Reply

TheFlash Jun. 25 at 5:20 PM

$ENVB Psychedelic: "Definium soars on study results for LSD-based depression treatment." Right up their alley. This will explode with news which should be soon. Chart at dead bottom.

0 · Reply

bioebi Jun. 24 at 11:50 PM

1 · Reply

bioebi Jun. 24 at 11:46 PM

$ENVB $CDT $DAIC $MWYN ENVB: this is my next 100% Runner

1 · Reply

Luckyjs38 Jun. 22 at 4:54 PM

$ENVB

0 · Reply

andre82 Jun. 22 at 3:42 PM

1 · Reply

yenkins Jun. 17 at 7:52 PM

$PSTV $NUWE $SINT $ENVB $JAGX

1 · Reply

BigBoyTroy Jun. 16 at 4:45 PM

$ENVB love this ticker I'm swinging this come join me in the free discord the link is in my stoctwits Profile my bullish 🐂 peeps

0 · Reply

focafoca99 Jun. 16 at 2:28 PM

$ENVB attends the 2026 BIO International Convention in San Diego.

0 · Reply

topstockalerts Jun. 14 at 10:35 PM

After Hours Top Gainers $SDOT $VSME $DLXY $ADTX $ENVB

0 · Reply

topstockalerts Jun. 14 at 1:10 PM

$ENVB keep an eye on it for tomorrow

0 · Reply

Ric_1M Jun. 14 at 11:17 AM

$SDOT $VSME $DLXY $WSO.B $ENVB "We take the stars from heaven, the red from our mother country, separating it by white stripes, thus showing that we have separated from her, and the white stripes shall go down to posterity, representing our liberty."🇺🇸 George Washington 🇺🇸

0 · Reply

topstockalerts Jun. 13 at 2:29 PM

$ENVB next week will be fun

1 · Reply

topstockalerts Jun. 13 at 12:43 AM

After Hours Top Gainers $SDOT $VSME $DXST $ADTX $ENVB

0 · Reply

NotCool Jun. 12 at 10:38 AM

$ENVB something is brewing. ??

0 · Reply

patrickhurney Jun. 12 at 9:05 AM

$ENVB looking to get filled in PM

1 · Reply

Market Cap	5.34M
Revenue (ttm)	0.00
Net Income (ttm)	-8.77M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	124,700
Avg Vol	1,346,878
Day's Range	N/A - N/A
Shares Out	3.68M
Stochastic %K	59%
Beta	1.15
Analysts	Strong Buy
Price Target	$10.00